Uncategorized
Anti-VEGF treatment may benefit patients with DME, vitreomacular adhesions
Anti-VEGF injections may improve visual outcomes in patients with diabetic macular edema who have vitreomacular adhesions, according to a substudy of READ-3.“VMA does not adversely influence treatment outcomes and therefore should not preclude patients with DME from receiving treatment with anti-VEGF agents,” study author Yasir J. Sepah, MBBS, told Ocular Surgery News.